nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—PTGS1—Ifosfamide—germ cell cancer	0.142	0.299	CbGbCtD
Sulindac—PTGS2—Cisplatin—germ cell cancer	0.0819	0.172	CbGbCtD
Sulindac—PTGS2—Etoposide—germ cell cancer	0.0805	0.169	CbGbCtD
Sulindac—PTGS1—Etoposide—germ cell cancer	0.068	0.143	CbGbCtD
Sulindac—SLC22A6—Methotrexate—germ cell cancer	0.0394	0.0827	CbGbCtD
Sulindac—ALB—Methotrexate—germ cell cancer	0.0335	0.0705	CbGbCtD
Sulindac—CYP1A2—Etoposide—germ cell cancer	0.0304	0.0638	CbGbCtD
Sulindac—AKR1B1—sciatic nerve—germ cell cancer	0.0216	0.12	CbGeAlD
Sulindac—MAPK3—adrenal medulla—germ cell cancer	0.0186	0.104	CbGeAlD
Sulindac—MAPK3—optic choroid—germ cell cancer	0.00972	0.0541	CbGeAlD
Sulindac—MAPK3—endothelium—germ cell cancer	0.00398	0.0222	CbGeAlD
Sulindac—MAPK3—blood vessel—germ cell cancer	0.00367	0.0205	CbGeAlD
Sulindac—AKR1B1—trigeminal ganglion—germ cell cancer	0.00313	0.0174	CbGeAlD
Sulindac—AKR1B1—embryo—germ cell cancer	0.00302	0.0168	CbGeAlD
Sulindac—AKR1B1—eye—germ cell cancer	0.0027	0.015	CbGeAlD
Sulindac—AKR1B1—retina—germ cell cancer	0.00267	0.0149	CbGeAlD
Sulindac—MAPK3—neck—germ cell cancer	0.00263	0.0146	CbGeAlD
Sulindac—PTGDR2—cerebellum—germ cell cancer	0.00257	0.0143	CbGeAlD
Sulindac—AKR1B1—telencephalon—germ cell cancer	0.00246	0.0137	CbGeAlD
Sulindac—AKR1B1—decidua—germ cell cancer	0.00233	0.013	CbGeAlD
Sulindac—MAPK3—trigeminal ganglion—germ cell cancer	0.00227	0.0126	CbGeAlD
Sulindac—MAPK3—embryo—germ cell cancer	0.00219	0.0122	CbGeAlD
Sulindac—CYP1A2—urine—germ cell cancer	0.00213	0.0118	CbGeAlD
Sulindac—PTGDR2—brain—germ cell cancer	0.00209	0.0116	CbGeAlD
Sulindac—AKR1B1—gonad—germ cell cancer	0.00205	0.0114	CbGeAlD
Sulindac—AKR1B1—uterus—germ cell cancer	0.00204	0.0114	CbGeAlD
Sulindac—AKR1B1—pituitary gland—germ cell cancer	0.002	0.0111	CbGeAlD
Sulindac—MAPK3—eye—germ cell cancer	0.00196	0.0109	CbGeAlD
Sulindac—MAPK3—retina—germ cell cancer	0.00194	0.0108	CbGeAlD
Sulindac—PPARD—telencephalon—germ cell cancer	0.00193	0.0108	CbGeAlD
Sulindac—AKR1B1—medulla oblongata—germ cell cancer	0.00193	0.0108	CbGeAlD
Sulindac—PPARD—decidua—germ cell cancer	0.00183	0.0102	CbGeAlD
Sulindac—AKR1B1—adrenal gland—germ cell cancer	0.00179	0.00996	CbGeAlD
Sulindac—MAPK3—telencephalon—germ cell cancer	0.00178	0.00993	CbGeAlD
Sulindac—AKR1B1—midbrain—germ cell cancer	0.00177	0.00983	CbGeAlD
Sulindac—AKR1B1—bone marrow—germ cell cancer	0.00173	0.00964	CbGeAlD
Sulindac—AKR1B1—spinal cord—germ cell cancer	0.00172	0.00959	CbGeAlD
Sulindac—PTGS2—appendage—germ cell cancer	0.00171	0.00955	CbGeAlD
Sulindac—MAPK3—skin of body—germ cell cancer	0.0017	0.00947	CbGeAlD
Sulindac—CYP1A1—skin epidermis—germ cell cancer	0.0017	0.00946	CbGeAlD
Sulindac—MAPK3—decidua—germ cell cancer	0.00169	0.00941	CbGeAlD
Sulindac—AKR1B1—female gonad—germ cell cancer	0.00167	0.00929	CbGeAlD
Sulindac—AKR1B1—endocrine gland—germ cell cancer	0.00155	0.00864	CbGeAlD
Sulindac—AKR1B1—head—germ cell cancer	0.00153	0.00853	CbGeAlD
Sulindac—MAPK3—gonad—germ cell cancer	0.00149	0.00828	CbGeAlD
Sulindac—AKR1B1—testis—germ cell cancer	0.00148	0.00824	CbGeAlD
Sulindac—MAPK3—uterus—germ cell cancer	0.00148	0.00823	CbGeAlD
Sulindac—MAPK3—pituitary gland—germ cell cancer	0.00145	0.00808	CbGeAlD
Sulindac—PTGS2—skin epidermis—germ cell cancer	0.00143	0.00794	CbGeAlD
Sulindac—PPARD—adrenal gland—germ cell cancer	0.00141	0.00783	CbGeAlD
Sulindac—MAPK3—medulla oblongata—germ cell cancer	0.0014	0.0078	CbGeAlD
Sulindac—PPARD—midbrain—germ cell cancer	0.00139	0.00773	CbGeAlD
Sulindac—AKR1B1—cerebellum—germ cell cancer	0.00137	0.00761	CbGeAlD
Sulindac—PPARD—female gonad—germ cell cancer	0.00131	0.0073	CbGeAlD
Sulindac—MAPK3—adrenal gland—germ cell cancer	0.0013	0.00722	CbGeAlD
Sulindac—MAPK3—midbrain—germ cell cancer	0.00128	0.00713	CbGeAlD
Sulindac—PTGS1—ganglion—germ cell cancer	0.00126	0.00699	CbGeAlD
Sulindac—MAPK3—bone marrow—germ cell cancer	0.00125	0.00698	CbGeAlD
Sulindac—MAPK3—spinal cord—germ cell cancer	0.00125	0.00695	CbGeAlD
Sulindac—PPARD—endocrine gland—germ cell cancer	0.00122	0.00679	CbGeAlD
Sulindac—MAPK3—female gonad—germ cell cancer	0.00121	0.00673	CbGeAlD
Sulindac—PPARD—head—germ cell cancer	0.0012	0.00671	CbGeAlD
Sulindac—PPARD—testis—germ cell cancer	0.00116	0.00648	CbGeAlD
Sulindac—MAPK3—endocrine gland—germ cell cancer	0.00112	0.00626	CbGeAlD
Sulindac—MAPK3—head—germ cell cancer	0.00111	0.00618	CbGeAlD
Sulindac—AKR1B1—brain—germ cell cancer	0.00111	0.00618	CbGeAlD
Sulindac—PTGS1—endothelium—germ cell cancer	0.00108	0.00603	CbGeAlD
Sulindac—PPARD—cerebellum—germ cell cancer	0.00107	0.00598	CbGeAlD
Sulindac—MAPK3—testis—germ cell cancer	0.00107	0.00597	CbGeAlD
Sulindac—AKR1B1—lymph node—germ cell cancer	0.00107	0.00597	CbGeAlD
Sulindac—PTGS2—endothelium—germ cell cancer	0.00104	0.00576	CbGeAlD
Sulindac—PTGS1—blood vessel—germ cell cancer	0.000999	0.00556	CbGeAlD
Sulindac—MAPK3—cerebellum—germ cell cancer	0.00099	0.00551	CbGeAlD
Sulindac—PTGS2—blood vessel—germ cell cancer	0.000955	0.00531	CbGeAlD
Sulindac—PPARD—brain—germ cell cancer	0.000873	0.00486	CbGeAlD
Sulindac—PPARD—lymph node—germ cell cancer	0.000843	0.00469	CbGeAlD
Sulindac—MAPK3—brain—germ cell cancer	0.000804	0.00448	CbGeAlD
Sulindac—MAPK3—lymph node—germ cell cancer	0.000777	0.00433	CbGeAlD
Sulindac—ALB—adrenal gland—germ cell cancer	0.000618	0.00344	CbGeAlD
Sulindac—SLC22A6—brain—germ cell cancer	0.000615	0.00343	CbGeAlD
Sulindac—PTGS2—trigeminal ganglion—germ cell cancer	0.00059	0.00328	CbGeAlD
Sulindac—PTGS2—embryo—germ cell cancer	0.000569	0.00317	CbGeAlD
Sulindac—Chills—Ifosfamide—germ cell cancer	0.000539	0.0028	CcSEcCtD
Sulindac—Arrhythmia—Ifosfamide—germ cell cancer	0.000537	0.00279	CcSEcCtD
Sulindac—Pneumonia—Etoposide—germ cell cancer	0.000532	0.00276	CcSEcCtD
Sulindac—Aplastic anaemia—Methotrexate—germ cell cancer	0.000531	0.00276	CcSEcCtD
Sulindac—Paraesthesia—Vinblastine—germ cell cancer	0.000531	0.00276	CcSEcCtD
Sulindac—Alopecia—Ifosfamide—germ cell cancer	0.000531	0.00276	CcSEcCtD
Sulindac—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00053	0.00275	CcSEcCtD
Sulindac—Anaemia—Dactinomycin—germ cell cancer	0.000528	0.00274	CcSEcCtD
Sulindac—CYP1A1—skin of body—germ cell cancer	0.000526	0.00293	CbGeAlD
Sulindac—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000524	0.00272	CcSEcCtD
Sulindac—Myalgia—Bleomycin—germ cell cancer	0.000521	0.00271	CcSEcCtD
Sulindac—Chest pain—Bleomycin—germ cell cancer	0.000521	0.00271	CcSEcCtD
Sulindac—Renal failure—Etoposide—germ cell cancer	0.00052	0.0027	CcSEcCtD
Sulindac—Neuropathy peripheral—Etoposide—germ cell cancer	0.000518	0.00269	CcSEcCtD
Sulindac—Coma—Methotrexate—germ cell cancer	0.000517	0.00269	CcSEcCtD
Sulindac—Stomatitis—Etoposide—germ cell cancer	0.000515	0.00268	CcSEcCtD
Sulindac—Jaundice—Etoposide—germ cell cancer	0.000515	0.00268	CcSEcCtD
Sulindac—Discomfort—Bleomycin—germ cell cancer	0.000515	0.00268	CcSEcCtD
Sulindac—Malaise—Dactinomycin—germ cell cancer	0.000515	0.00268	CcSEcCtD
Sulindac—Decreased appetite—Vinblastine—germ cell cancer	0.000514	0.00267	CcSEcCtD
Sulindac—Ecchymosis—Methotrexate—germ cell cancer	0.000512	0.00266	CcSEcCtD
Sulindac—ALB—testis—germ cell cancer	0.000511	0.00285	CbGeAlD
Sulindac—Leukopenia—Dactinomycin—germ cell cancer	0.000511	0.00266	CcSEcCtD
Sulindac—Gynaecomastia—Methotrexate—germ cell cancer	0.000506	0.00263	CcSEcCtD
Sulindac—Constipation—Vinblastine—germ cell cancer	0.000506	0.00263	CcSEcCtD
Sulindac—Anaphylactic shock—Bleomycin—germ cell cancer	0.0005	0.0026	CcSEcCtD
Sulindac—Oedema—Bleomycin—germ cell cancer	0.0005	0.0026	CcSEcCtD
Sulindac—Visual impairment—Cisplatin—germ cell cancer	0.000499	0.0026	CcSEcCtD
Sulindac—Agranulocytosis—Etoposide—germ cell cancer	0.000493	0.00256	CcSEcCtD
Sulindac—Vision blurred—Ifosfamide—germ cell cancer	0.000493	0.00256	CcSEcCtD
Sulindac—Thrombocytopenia—Bleomycin—germ cell cancer	0.000489	0.00254	CcSEcCtD
Sulindac—Feeling abnormal—Vinblastine—germ cell cancer	0.000487	0.00253	CcSEcCtD
Sulindac—Myalgia—Dactinomycin—germ cell cancer	0.000486	0.00253	CcSEcCtD
Sulindac—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000485	0.00252	CcSEcCtD
Sulindac—PTGS1—telencephalon—germ cell cancer	0.000484	0.0027	CbGeAlD
Sulindac—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000484	0.00251	CcSEcCtD
Sulindac—Anaemia—Ifosfamide—germ cell cancer	0.000483	0.00251	CcSEcCtD
Sulindac—Tinnitus—Cisplatin—germ cell cancer	0.000483	0.00251	CcSEcCtD
Sulindac—Flushing—Cisplatin—germ cell cancer	0.000481	0.0025	CcSEcCtD
Sulindac—Discomfort—Dactinomycin—germ cell cancer	0.00048	0.0025	CcSEcCtD
Sulindac—Angioedema—Ifosfamide—germ cell cancer	0.000478	0.00248	CcSEcCtD
Sulindac—Anorexia—Bleomycin—germ cell cancer	0.000476	0.00248	CcSEcCtD
Sulindac—Malaise—Ifosfamide—germ cell cancer	0.000472	0.00245	CcSEcCtD
Sulindac—Vertigo—Ifosfamide—germ cell cancer	0.00047	0.00244	CcSEcCtD
Sulindac—Leukopenia—Ifosfamide—germ cell cancer	0.000468	0.00243	CcSEcCtD
Sulindac—Photosensitivity—Methotrexate—germ cell cancer	0.000468	0.00243	CcSEcCtD
Sulindac—Hypotension—Bleomycin—germ cell cancer	0.000467	0.00243	CcSEcCtD
Sulindac—Oedema—Dactinomycin—germ cell cancer	0.000466	0.00242	CcSEcCtD
Sulindac—PTGS2—telencephalon—germ cell cancer	0.000463	0.00258	CbGeAlD
Sulindac—Arrhythmia—Cisplatin—germ cell cancer	0.000463	0.00241	CcSEcCtD
Sulindac—PTGS1—skin of body—germ cell cancer	0.000462	0.00257	CbGeAlD
Sulindac—Palpitations—Ifosfamide—germ cell cancer	0.000462	0.0024	CcSEcCtD
Sulindac—Alopecia—Cisplatin—germ cell cancer	0.000458	0.00238	CcSEcCtD
Sulindac—Hepatic failure—Methotrexate—germ cell cancer	0.000457	0.00238	CcSEcCtD
Sulindac—CYP1A1—uterus—germ cell cancer	0.000457	0.00255	CbGeAlD
Sulindac—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000456	0.00237	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000455	0.00237	CcSEcCtD
Sulindac—Convulsion—Ifosfamide—germ cell cancer	0.000453	0.00236	CcSEcCtD
Sulindac—Hypertension—Ifosfamide—germ cell cancer	0.000452	0.00235	CcSEcCtD
Sulindac—Erythema multiforme—Etoposide—germ cell cancer	0.000449	0.00233	CcSEcCtD
Sulindac—Paraesthesia—Bleomycin—germ cell cancer	0.000449	0.00233	CcSEcCtD
Sulindac—Dyspnoea—Bleomycin—germ cell cancer	0.000445	0.00232	CcSEcCtD
Sulindac—Myalgia—Ifosfamide—germ cell cancer	0.000445	0.00232	CcSEcCtD
Sulindac—Chest pain—Ifosfamide—germ cell cancer	0.000445	0.00232	CcSEcCtD
Sulindac—Arthralgia—Ifosfamide—germ cell cancer	0.000445	0.00232	CcSEcCtD
Sulindac—Flatulence—Cisplatin—germ cell cancer	0.000444	0.00231	CcSEcCtD
Sulindac—Anorexia—Dactinomycin—germ cell cancer	0.000444	0.00231	CcSEcCtD
Sulindac—PTGS2—skin of body—germ cell cancer	0.000442	0.00246	CbGeAlD
Sulindac—Flushing—Etoposide—germ cell cancer	0.00044	0.00229	CcSEcCtD
Sulindac—Discomfort—Ifosfamide—germ cell cancer	0.00044	0.00229	CcSEcCtD
Sulindac—Hypersensitivity—Vinblastine—germ cell cancer	0.000436	0.00227	CcSEcCtD
Sulindac—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000435	0.00226	CcSEcCtD
Sulindac—Decreased appetite—Bleomycin—germ cell cancer	0.000434	0.00226	CcSEcCtD
Sulindac—Visual disturbance—Methotrexate—germ cell cancer	0.000434	0.00225	CcSEcCtD
Sulindac—Oedema—Ifosfamide—germ cell cancer	0.000427	0.00222	CcSEcCtD
Sulindac—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000427	0.00222	CcSEcCtD
Sulindac—Chills—Etoposide—germ cell cancer	0.000426	0.00221	CcSEcCtD
Sulindac—Vision blurred—Cisplatin—germ cell cancer	0.000425	0.00221	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000424	0.00221	CcSEcCtD
Sulindac—Asthenia—Vinblastine—germ cell cancer	0.000424	0.00221	CcSEcCtD
Sulindac—Alopecia—Etoposide—germ cell cancer	0.000419	0.00218	CcSEcCtD
Sulindac—Ill-defined disorder—Cisplatin—germ cell cancer	0.000418	0.00218	CcSEcCtD
Sulindac—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000418	0.00217	CcSEcCtD
Sulindac—Anaemia—Cisplatin—germ cell cancer	0.000417	0.00217	CcSEcCtD
Sulindac—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000413	0.00215	CcSEcCtD
Sulindac—Feeling abnormal—Bleomycin—germ cell cancer	0.000412	0.00214	CcSEcCtD
Sulindac—Anorexia—Ifosfamide—germ cell cancer	0.000407	0.00212	CcSEcCtD
Sulindac—Malaise—Cisplatin—germ cell cancer	0.000407	0.00211	CcSEcCtD
Sulindac—Decreased appetite—Dactinomycin—germ cell cancer	0.000405	0.00211	CcSEcCtD
Sulindac—Diarrhoea—Vinblastine—germ cell cancer	0.000405	0.0021	CcSEcCtD
Sulindac—Dysgeusia—Etoposide—germ cell cancer	0.000405	0.0021	CcSEcCtD
Sulindac—Leukopenia—Cisplatin—germ cell cancer	0.000404	0.0021	CcSEcCtD
Sulindac—PTGS1—uterus—germ cell cancer	0.000402	0.00224	CbGeAlD
Sulindac—Fatigue—Dactinomycin—germ cell cancer	0.000402	0.00209	CcSEcCtD
Sulindac—Hypotension—Ifosfamide—germ cell cancer	0.000399	0.00207	CcSEcCtD
Sulindac—Urticaria—Bleomycin—germ cell cancer	0.000397	0.00206	CcSEcCtD
Sulindac—Body temperature increased—Bleomycin—germ cell cancer	0.000395	0.00205	CcSEcCtD
Sulindac—PTGS1—pituitary gland—germ cell cancer	0.000394	0.0022	CbGeAlD
Sulindac—Dizziness—Vinblastine—germ cell cancer	0.000391	0.00203	CcSEcCtD
Sulindac—Convulsion—Cisplatin—germ cell cancer	0.000391	0.00203	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000389	0.00202	CcSEcCtD
Sulindac—PTGS2—uterus—germ cell cancer	0.000384	0.00214	CbGeAlD
Sulindac—Myalgia—Cisplatin—germ cell cancer	0.000384	0.002	CcSEcCtD
Sulindac—Feeling abnormal—Dactinomycin—germ cell cancer	0.000384	0.002	CcSEcCtD
Sulindac—ALB—brain—germ cell cancer	0.000384	0.00214	CbGeAlD
Sulindac—Paraesthesia—Ifosfamide—germ cell cancer	0.000383	0.00199	CcSEcCtD
Sulindac—Ill-defined disorder—Etoposide—germ cell cancer	0.000383	0.00199	CcSEcCtD
Sulindac—Anaemia—Etoposide—germ cell cancer	0.000382	0.00199	CcSEcCtD
Sulindac—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000381	0.00198	CcSEcCtD
Sulindac—Dyspnoea—Ifosfamide—germ cell cancer	0.000381	0.00198	CcSEcCtD
Sulindac—Somnolence—Ifosfamide—germ cell cancer	0.00038	0.00197	CcSEcCtD
Sulindac—Discomfort—Cisplatin—germ cell cancer	0.000379	0.00197	CcSEcCtD
Sulindac—PTGS2—pituitary gland—germ cell cancer	0.000377	0.0021	CbGeAlD
Sulindac—Vomiting—Vinblastine—germ cell cancer	0.000376	0.00195	CcSEcCtD
Sulindac—CYP1A1—female gonad—germ cell cancer	0.000374	0.00208	CbGeAlD
Sulindac—Malaise—Etoposide—germ cell cancer	0.000373	0.00194	CcSEcCtD
Sulindac—Vertigo—Etoposide—germ cell cancer	0.000371	0.00193	CcSEcCtD
Sulindac—Decreased appetite—Ifosfamide—germ cell cancer	0.000371	0.00193	CcSEcCtD
Sulindac—ALB—lymph node—germ cell cancer	0.000371	0.00206	CbGeAlD
Sulindac—Headache—Vinblastine—germ cell cancer	0.000371	0.00193	CcSEcCtD
Sulindac—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.00037	0.00192	CcSEcCtD
Sulindac—Leukopenia—Etoposide—germ cell cancer	0.00037	0.00192	CcSEcCtD
Sulindac—Body temperature increased—Dactinomycin—germ cell cancer	0.000368	0.00191	CcSEcCtD
Sulindac—Fatigue—Ifosfamide—germ cell cancer	0.000368	0.00191	CcSEcCtD
Sulindac—Oedema—Cisplatin—germ cell cancer	0.000368	0.00191	CcSEcCtD
Sulindac—Anaphylactic shock—Cisplatin—germ cell cancer	0.000368	0.00191	CcSEcCtD
Sulindac—Hypersensitivity—Bleomycin—germ cell cancer	0.000368	0.00191	CcSEcCtD
Sulindac—Constipation—Ifosfamide—germ cell cancer	0.000365	0.0019	CcSEcCtD
Sulindac—PTGS2—medulla oblongata—germ cell cancer	0.000364	0.00203	CbGeAlD
Sulindac—Loss of consciousness—Etoposide—germ cell cancer	0.000363	0.00189	CcSEcCtD
Sulindac—Thrombocytopenia—Cisplatin—germ cell cancer	0.00036	0.00187	CcSEcCtD
Sulindac—Tachycardia—Cisplatin—germ cell cancer	0.000359	0.00187	CcSEcCtD
Sulindac—Asthenia—Bleomycin—germ cell cancer	0.000358	0.00186	CcSEcCtD
Sulindac—Convulsion—Etoposide—germ cell cancer	0.000358	0.00186	CcSEcCtD
Sulindac—Hypertension—Etoposide—germ cell cancer	0.000357	0.00185	CcSEcCtD
Sulindac—Hyperhidrosis—Cisplatin—germ cell cancer	0.000356	0.00185	CcSEcCtD
Sulindac—Pruritus—Bleomycin—germ cell cancer	0.000353	0.00184	CcSEcCtD
Sulindac—CYP1A2—endocrine gland—germ cell cancer	0.000353	0.00196	CbGeAlD
Sulindac—PTGS1—adrenal gland—germ cell cancer	0.000352	0.00196	CbGeAlD
Sulindac—Feeling abnormal—Ifosfamide—germ cell cancer	0.000352	0.00183	CcSEcCtD
Sulindac—Chest pain—Etoposide—germ cell cancer	0.000352	0.00183	CcSEcCtD
Sulindac—Eosinophilia—Methotrexate—germ cell cancer	0.000352	0.00183	CcSEcCtD
Sulindac—Nausea—Vinblastine—germ cell cancer	0.000351	0.00183	CcSEcCtD
Sulindac—Anorexia—Cisplatin—germ cell cancer	0.000351	0.00182	CcSEcCtD
Sulindac—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000349	0.00181	CcSEcCtD
Sulindac—Pancreatitis—Methotrexate—germ cell cancer	0.000348	0.00181	CcSEcCtD
Sulindac—CYP1A1—endocrine gland—germ cell cancer	0.000348	0.00194	CbGeAlD
Sulindac—Discomfort—Etoposide—germ cell cancer	0.000348	0.00181	CcSEcCtD
Sulindac—Hypotension—Cisplatin—germ cell cancer	0.000344	0.00179	CcSEcCtD
Sulindac—CYP1A1—head—germ cell cancer	0.000343	0.00191	CbGeAlD
Sulindac—Hypersensitivity—Dactinomycin—germ cell cancer	0.000343	0.00178	CcSEcCtD
Sulindac—PTGS1—spinal cord—germ cell cancer	0.000339	0.00189	CbGeAlD
Sulindac—Urticaria—Ifosfamide—germ cell cancer	0.000339	0.00176	CcSEcCtD
Sulindac—Body temperature increased—Ifosfamide—germ cell cancer	0.000337	0.00175	CcSEcCtD
Sulindac—Pancytopenia—Methotrexate—germ cell cancer	0.000337	0.00175	CcSEcCtD
Sulindac—Anaphylactic shock—Etoposide—germ cell cancer	0.000337	0.00175	CcSEcCtD
Sulindac—PTGS2—adrenal gland—germ cell cancer	0.000337	0.00188	CbGeAlD
Sulindac—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000335	0.00174	CcSEcCtD
Sulindac—Asthenia—Dactinomycin—germ cell cancer	0.000334	0.00174	CcSEcCtD
Sulindac—PTGS2—midbrain—germ cell cancer	0.000333	0.00185	CbGeAlD
Sulindac—Neutropenia—Methotrexate—germ cell cancer	0.000332	0.00173	CcSEcCtD
Sulindac—Dysuria—Methotrexate—germ cell cancer	0.000332	0.00173	CcSEcCtD
Sulindac—Paraesthesia—Cisplatin—germ cell cancer	0.00033	0.00172	CcSEcCtD
Sulindac—Thrombocytopenia—Etoposide—germ cell cancer	0.00033	0.00172	CcSEcCtD
Sulindac—Tachycardia—Etoposide—germ cell cancer	0.000329	0.00171	CcSEcCtD
Sulindac—PTGS1—female gonad—germ cell cancer	0.000329	0.00183	CbGeAlD
Sulindac—Dyspnoea—Cisplatin—germ cell cancer	0.000328	0.00171	CcSEcCtD
Sulindac—Hyperhidrosis—Etoposide—germ cell cancer	0.000326	0.00169	CcSEcCtD
Sulindac—PTGS2—bone marrow—germ cell cancer	0.000326	0.00181	CbGeAlD
Sulindac—PTGS2—spinal cord—germ cell cancer	0.000324	0.00181	CbGeAlD
Sulindac—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000324	0.00169	CcSEcCtD
Sulindac—Anorexia—Etoposide—germ cell cancer	0.000321	0.00167	CcSEcCtD
Sulindac—Decreased appetite—Cisplatin—germ cell cancer	0.00032	0.00166	CcSEcCtD
Sulindac—Diarrhoea—Dactinomycin—germ cell cancer	0.000319	0.00166	CcSEcCtD
Sulindac—Pneumonia—Methotrexate—germ cell cancer	0.000319	0.00166	CcSEcCtD
Sulindac—Vomiting—Bleomycin—germ cell cancer	0.000318	0.00165	CcSEcCtD
Sulindac—Depression—Methotrexate—germ cell cancer	0.000316	0.00164	CcSEcCtD
Sulindac—Hypotension—Etoposide—germ cell cancer	0.000315	0.00164	CcSEcCtD
Sulindac—Rash—Bleomycin—germ cell cancer	0.000315	0.00164	CcSEcCtD
Sulindac—Dermatitis—Bleomycin—germ cell cancer	0.000315	0.00164	CcSEcCtD
Sulindac—Hypersensitivity—Ifosfamide—germ cell cancer	0.000315	0.00164	CcSEcCtD
Sulindac—PTGS2—female gonad—germ cell cancer	0.000314	0.00175	CbGeAlD
Sulindac—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000314	0.00163	CcSEcCtD
Sulindac—Renal failure—Methotrexate—germ cell cancer	0.000311	0.00162	CcSEcCtD
Sulindac—Stomatitis—Methotrexate—germ cell cancer	0.000309	0.0016	CcSEcCtD
Sulindac—Conjunctivitis—Methotrexate—germ cell cancer	0.000308	0.0016	CcSEcCtD
Sulindac—Asthenia—Ifosfamide—germ cell cancer	0.000306	0.00159	CcSEcCtD
Sulindac—PTGS1—endocrine gland—germ cell cancer	0.000306	0.0017	CbGeAlD
Sulindac—Sweating—Methotrexate—germ cell cancer	0.000304	0.00158	CcSEcCtD
Sulindac—Feeling abnormal—Cisplatin—germ cell cancer	0.000303	0.00158	CcSEcCtD
Sulindac—Paraesthesia—Etoposide—germ cell cancer	0.000303	0.00157	CcSEcCtD
Sulindac—Pruritus—Ifosfamide—germ cell cancer	0.000302	0.00157	CcSEcCtD
Sulindac—Haematuria—Methotrexate—germ cell cancer	0.000302	0.00157	CcSEcCtD
Sulindac—PTGS1—head—germ cell cancer	0.000302	0.00168	CbGeAlD
Sulindac—Dyspnoea—Etoposide—germ cell cancer	0.000301	0.00156	CcSEcCtD
Sulindac—Somnolence—Etoposide—germ cell cancer	0.0003	0.00156	CcSEcCtD
Sulindac—Epistaxis—Methotrexate—germ cell cancer	0.000299	0.00155	CcSEcCtD
Sulindac—Nausea—Bleomycin—germ cell cancer	0.000297	0.00154	CcSEcCtD
Sulindac—Vomiting—Dactinomycin—germ cell cancer	0.000296	0.00154	CcSEcCtD
Sulindac—Agranulocytosis—Methotrexate—germ cell cancer	0.000296	0.00154	CcSEcCtD
Sulindac—Rash—Dactinomycin—germ cell cancer	0.000294	0.00153	CcSEcCtD
Sulindac—Decreased appetite—Etoposide—germ cell cancer	0.000293	0.00152	CcSEcCtD
Sulindac—Diarrhoea—Ifosfamide—germ cell cancer	0.000292	0.00152	CcSEcCtD
Sulindac—PTGS2—endocrine gland—germ cell cancer	0.000292	0.00163	CbGeAlD
Sulindac—PTGS1—testis—germ cell cancer	0.000291	0.00162	CbGeAlD
Sulindac—Body temperature increased—Cisplatin—germ cell cancer	0.000291	0.00151	CcSEcCtD
Sulindac—Fatigue—Etoposide—germ cell cancer	0.000291	0.00151	CcSEcCtD
Sulindac—PTGS2—head—germ cell cancer	0.000288	0.00161	CbGeAlD
Sulindac—Constipation—Etoposide—germ cell cancer	0.000288	0.0015	CcSEcCtD
Sulindac—Hepatitis—Methotrexate—germ cell cancer	0.000284	0.00148	CcSEcCtD
Sulindac—Dizziness—Ifosfamide—germ cell cancer	0.000282	0.00147	CcSEcCtD
Sulindac—Feeling abnormal—Etoposide—germ cell cancer	0.000278	0.00144	CcSEcCtD
Sulindac—Nausea—Dactinomycin—germ cell cancer	0.000277	0.00144	CcSEcCtD
Sulindac—Gastrointestinal pain—Etoposide—germ cell cancer	0.000276	0.00143	CcSEcCtD
Sulindac—Visual impairment—Methotrexate—germ cell cancer	0.000274	0.00142	CcSEcCtD
Sulindac—Vomiting—Ifosfamide—germ cell cancer	0.000271	0.00141	CcSEcCtD
Sulindac—Hypersensitivity—Cisplatin—germ cell cancer	0.000271	0.00141	CcSEcCtD
Sulindac—Rash—Ifosfamide—germ cell cancer	0.000269	0.0014	CcSEcCtD
Sulindac—Dermatitis—Ifosfamide—germ cell cancer	0.000269	0.0014	CcSEcCtD
Sulindac—Erythema multiforme—Methotrexate—germ cell cancer	0.000269	0.0014	CcSEcCtD
Sulindac—Urticaria—Etoposide—germ cell cancer	0.000268	0.00139	CcSEcCtD
Sulindac—Body temperature increased—Etoposide—germ cell cancer	0.000267	0.00139	CcSEcCtD
Sulindac—Tinnitus—Methotrexate—germ cell cancer	0.000265	0.00138	CcSEcCtD
Sulindac—MAPK3—PDGF Pathway—HRAS—germ cell cancer	0.000264	0.00174	CbGpPWpGaD
Sulindac—MAPK3—Signaling events regulated by Ret tyrosine kinase—HRAS—germ cell cancer	0.000264	0.00174	CbGpPWpGaD
Sulindac—MAPK3—EPHB forward signaling—HRAS—germ cell cancer	0.000264	0.00174	CbGpPWpGaD
Sulindac—Asthenia—Cisplatin—germ cell cancer	0.000264	0.00137	CcSEcCtD
Sulindac—MAPK3—Signaling by EGFR in Cancer—KITLG—germ cell cancer	0.000263	0.00173	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—KITLG—germ cell cancer	0.000261	0.00172	CbGpPWpGaD
Sulindac—MAPK3—IL2-mediated signaling events—MYC—germ cell cancer	0.000259	0.00171	CbGpPWpGaD
Sulindac—PTGS2—cerebellum—germ cell cancer	0.000257	0.00143	CbGeAlD
Sulindac—Chills—Methotrexate—germ cell cancer	0.000255	0.00133	CcSEcCtD
Sulindac—MAPK3—ErbB2/ErbB3 signaling events—HRAS—germ cell cancer	0.000254	0.00167	CbGpPWpGaD
Sulindac—Nausea—Ifosfamide—germ cell cancer	0.000254	0.00132	CcSEcCtD
Sulindac—Diarrhoea—Cisplatin—germ cell cancer	0.000252	0.00131	CcSEcCtD
Sulindac—Alopecia—Methotrexate—germ cell cancer	0.000251	0.00131	CcSEcCtD
Sulindac—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—germ cell cancer	0.000251	0.00165	CbGpPWpGaD
Sulindac—MAPK3—IL-2 Signaling Pathway—HRAS—germ cell cancer	0.000249	0.00164	CbGpPWpGaD
Sulindac—CYP1A1—brain—germ cell cancer	0.000249	0.00139	CbGeAlD
Sulindac—Hypersensitivity—Etoposide—germ cell cancer	0.000248	0.00129	CcSEcCtD
Sulindac—PTGDR2—GPCR downstream signaling—AVP—germ cell cancer	0.000248	0.00163	CbGpPWpGaD
Sulindac—MAPK3—FCERI mediated MAPK activation—HRAS—germ cell cancer	0.000244	0.00161	CbGpPWpGaD
Sulindac—Dysgeusia—Methotrexate—germ cell cancer	0.000242	0.00126	CcSEcCtD
Sulindac—Asthenia—Etoposide—germ cell cancer	0.000242	0.00126	CcSEcCtD
Sulindac—CYP1A1—lymph node—germ cell cancer	0.00024	0.00134	CbGeAlD
Sulindac—MAPK3—Interleukin-11 Signaling Pathway—HRAS—germ cell cancer	0.00024	0.00158	CbGpPWpGaD
Sulindac—MAPK3—Signalling to ERKs—HRAS—germ cell cancer	0.00024	0.00158	CbGpPWpGaD
Sulindac—MAPK3—FRS2-mediated cascade—HRAS—germ cell cancer	0.00024	0.00158	CbGpPWpGaD
Sulindac—PPARD—Ectoderm Differentiation—MYC—germ cell cancer	0.00024	0.00158	CbGpPWpGaD
Sulindac—Pruritus—Etoposide—germ cell cancer	0.000239	0.00124	CcSEcCtD
Sulindac—MAPK3—Signaling by SCF-KIT—FGFR3—germ cell cancer	0.000238	0.00157	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—CD9—germ cell cancer	0.000237	0.00156	CbGpPWpGaD
Sulindac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	0.000237	0.00156	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—KITLG—germ cell cancer	0.000237	0.00156	CbGpPWpGaD
Sulindac—MAPK3—Transcription—H2AFZ—germ cell cancer	0.000235	0.00154	CbGpPWpGaD
Sulindac—Vomiting—Cisplatin—germ cell cancer	0.000234	0.00122	CcSEcCtD
Sulindac—Vision blurred—Methotrexate—germ cell cancer	0.000233	0.00121	CcSEcCtD
Sulindac—Rash—Cisplatin—germ cell cancer	0.000232	0.00121	CcSEcCtD
Sulindac—Dermatitis—Cisplatin—germ cell cancer	0.000232	0.00121	CcSEcCtD
Sulindac—Diarrhoea—Etoposide—germ cell cancer	0.000231	0.0012	CcSEcCtD
Sulindac—Ill-defined disorder—Methotrexate—germ cell cancer	0.00023	0.00119	CcSEcCtD
Sulindac—Anaemia—Methotrexate—germ cell cancer	0.000229	0.00119	CcSEcCtD
Sulindac—MAPK3—Downstream signaling of activated FGFR—FGFR3—germ cell cancer	0.000228	0.0015	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	0.000228	0.0015	CbGpPWpGaD
Sulindac—MAPK3—Interleukin-2 signaling—HRAS—germ cell cancer	0.000228	0.0015	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—AVP—germ cell cancer	0.000225	0.00148	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—FGFR3—germ cell cancer	0.000224	0.00148	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000224	0.00147	CbGpPWpGaD
Sulindac—Malaise—Methotrexate—germ cell cancer	0.000223	0.00116	CcSEcCtD
Sulindac—Dizziness—Etoposide—germ cell cancer	0.000223	0.00116	CcSEcCtD
Sulindac—Vertigo—Methotrexate—germ cell cancer	0.000222	0.00116	CcSEcCtD
Sulindac—MAPK3—Signaling by NGF—FGF4—germ cell cancer	0.000222	0.00146	CbGpPWpGaD
Sulindac—Leukopenia—Methotrexate—germ cell cancer	0.000222	0.00115	CcSEcCtD
Sulindac—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000221	0.00146	CbGpPWpGaD
Sulindac—MAPK3—TSH signaling pathway—MYC—germ cell cancer	0.000221	0.00145	CbGpPWpGaD
Sulindac—MAPK3—IL-3 Signaling Pathway—HRAS—germ cell cancer	0.00022	0.00145	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—KIT—germ cell cancer	0.000219	0.00144	CbGpPWpGaD
Sulindac—Nausea—Cisplatin—germ cell cancer	0.000219	0.00114	CcSEcCtD
Sulindac—PTGS1—brain—germ cell cancer	0.000219	0.00122	CbGeAlD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—MYC—germ cell cancer	0.000218	0.00144	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—MYC—germ cell cancer	0.000216	0.00142	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NR0B1—germ cell cancer	0.000215	0.00142	CbGpPWpGaD
Sulindac—Convulsion—Methotrexate—germ cell cancer	0.000214	0.00111	CcSEcCtD
Sulindac—Vomiting—Etoposide—germ cell cancer	0.000214	0.00111	CcSEcCtD
Sulindac—MAPK3—Downstream signal transduction—FGFR3—germ cell cancer	0.000214	0.00141	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Stem cell factor receptor (c-Kit)—HRAS—germ cell cancer	0.000213	0.0014	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—FGFR3—germ cell cancer	0.000213	0.0014	CbGpPWpGaD
Sulindac—Rash—Etoposide—germ cell cancer	0.000213	0.00111	CcSEcCtD
Sulindac—Dermatitis—Etoposide—germ cell cancer	0.000212	0.0011	CcSEcCtD
Sulindac—MAPK3—Signaling by ERBB2—FGFR3—germ cell cancer	0.000212	0.0014	CbGpPWpGaD
Sulindac—PTGS1—lymph node—germ cell cancer	0.000211	0.00118	CbGeAlD
Sulindac—Headache—Etoposide—germ cell cancer	0.000211	0.0011	CcSEcCtD
Sulindac—MAPK3—DAP12 signaling—FGFR3—germ cell cancer	0.000211	0.00139	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—H2AFZ—germ cell cancer	0.000211	0.00139	CbGpPWpGaD
Sulindac—Arthralgia—Methotrexate—germ cell cancer	0.000211	0.0011	CcSEcCtD
Sulindac—Myalgia—Methotrexate—germ cell cancer	0.000211	0.0011	CcSEcCtD
Sulindac—Chest pain—Methotrexate—germ cell cancer	0.000211	0.0011	CcSEcCtD
Sulindac—MAPK3—Downstream signaling of activated FGFR—KIT—germ cell cancer	0.000209	0.00138	CbGpPWpGaD
Sulindac—PTGS2—brain—germ cell cancer	0.000209	0.00116	CbGeAlD
Sulindac—Discomfort—Methotrexate—germ cell cancer	0.000208	0.00108	CcSEcCtD
Sulindac—MAPK3—Signaling by ERBB4—KIT—germ cell cancer	0.000206	0.00135	CbGpPWpGaD
Sulindac—MAPK3—TGF-beta Receptor Signaling—HRAS—germ cell cancer	0.000204	0.00134	CbGpPWpGaD
Sulindac—MAPK3—IL2-mediated signaling events—HRAS—germ cell cancer	0.000204	0.00134	CbGpPWpGaD
Sulindac—Anaphylactic shock—Methotrexate—germ cell cancer	0.000202	0.00105	CcSEcCtD
Sulindac—PTGS2—lymph node—germ cell cancer	0.000202	0.00112	CbGeAlD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.0002	0.00132	CbGpPWpGaD
Sulindac—Nausea—Etoposide—germ cell cancer	0.0002	0.00104	CcSEcCtD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	0.000199	0.00131	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—FGFR3—germ cell cancer	0.000199	0.00131	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—FGFR3—germ cell cancer	0.000199	0.00131	CbGpPWpGaD
Sulindac—Thrombocytopenia—Methotrexate—germ cell cancer	0.000198	0.00103	CcSEcCtD
Sulindac—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000197	0.0013	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—KIT—germ cell cancer	0.000197	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—FGFR3—germ cell cancer	0.000197	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—KIT—germ cell cancer	0.000197	0.00129	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000196	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—KIT—germ cell cancer	0.000196	0.00129	CbGpPWpGaD
Sulindac—Hyperhidrosis—Methotrexate—germ cell cancer	0.000195	0.00101	CcSEcCtD
Sulindac—MAPK3—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	0.000195	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—SOX2—germ cell cancer	0.000195	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—KIT—germ cell cancer	0.000195	0.00128	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—OXT—germ cell cancer	0.000194	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—FGFR3—germ cell cancer	0.000194	0.00128	CbGpPWpGaD
Sulindac—PPARD—Metabolism—SLC2A3—germ cell cancer	0.000194	0.00128	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—KIT—germ cell cancer	0.000194	0.00127	CbGpPWpGaD
Sulindac—MAPK3—M Phase—H2AFZ—germ cell cancer	0.000193	0.00127	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000193	0.00127	CbGpPWpGaD
Sulindac—Anorexia—Methotrexate—germ cell cancer	0.000193	0.001	CcSEcCtD
Sulindac—PPARD—Metabolism—SLC22A3—germ cell cancer	0.000191	0.00126	CbGpPWpGaD
Sulindac—MAPK3—Kit receptor signaling pathway—HRAS—germ cell cancer	0.00019	0.00125	CbGpPWpGaD
Sulindac—Hypotension—Methotrexate—germ cell cancer	0.000189	0.000981	CcSEcCtD
Sulindac—MAPK3—Gene Expression—DNMT3L—germ cell cancer	0.000187	0.00123	CbGpPWpGaD
Sulindac—MAPK3—Neurotrophic factor-mediated Trk receptor signaling—HRAS—germ cell cancer	0.000185	0.00122	CbGpPWpGaD
Sulindac—MAPK3—Fc-epsilon receptor I signaling in mast cells—HRAS—germ cell cancer	0.000185	0.00122	CbGpPWpGaD
Sulindac—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000184	0.000957	CcSEcCtD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—TP53—germ cell cancer	0.000184	0.00121	CbGpPWpGaD
Sulindac—Insomnia—Methotrexate—germ cell cancer	0.000183	0.00095	CcSEcCtD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	0.000182	0.0012	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—KIT—germ cell cancer	0.000182	0.0012	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—KIT—germ cell cancer	0.000182	0.0012	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—KITLG—germ cell cancer	0.000182	0.0012	CbGpPWpGaD
Sulindac—Paraesthesia—Methotrexate—germ cell cancer	0.000181	0.000943	CcSEcCtD
Sulindac—MAPK3—Signaling by EGFR—KIT—germ cell cancer	0.000181	0.00119	CbGpPWpGaD
Sulindac—MAPK3—Endothelins—HRAS—germ cell cancer	0.00018	0.00118	CbGpPWpGaD
Sulindac—Dyspnoea—Methotrexate—germ cell cancer	0.00018	0.000936	CcSEcCtD
Sulindac—Somnolence—Methotrexate—germ cell cancer	0.00018	0.000933	CcSEcCtD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—TP53—germ cell cancer	0.000179	0.00118	CbGpPWpGaD
Sulindac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—germ cell cancer	0.000179	0.00118	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—KIT—germ cell cancer	0.000179	0.00118	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—KIT—germ cell cancer	0.000178	0.00117	CbGpPWpGaD
Sulindac—Dyspepsia—Methotrexate—germ cell cancer	0.000178	0.000924	CcSEcCtD
Sulindac—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000178	0.00117	CbGpPWpGaD
Sulindac—MAPK3—Mitotic M-M/G1 phases—H2AFZ—germ cell cancer	0.000177	0.00116	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	0.000176	0.00116	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—HRAS—germ cell cancer	0.000176	0.00116	CbGpPWpGaD
Sulindac—Decreased appetite—Methotrexate—germ cell cancer	0.000176	0.000913	CcSEcCtD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000175	0.00115	CbGpPWpGaD
Sulindac—Fatigue—Methotrexate—germ cell cancer	0.000174	0.000905	CcSEcCtD
Sulindac—MAPK3—Gene Expression—RARS—germ cell cancer	0.000174	0.00114	CbGpPWpGaD
Sulindac—MAPK3—TSH signaling pathway—HRAS—germ cell cancer	0.000174	0.00114	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling in naïve CD8+ T cells—HRAS—germ cell cancer	0.000174	0.00114	CbGpPWpGaD
Sulindac—MAPK3—mTOR signaling pathway—HRAS—germ cell cancer	0.000174	0.00114	CbGpPWpGaD
Sulindac—MAPK3—BCR signaling pathway—HRAS—germ cell cancer	0.000171	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—HRAS—germ cell cancer	0.000171	0.00113	CbGpPWpGaD
Sulindac—MAPK3—NCAM signaling for neurite out-growth—HRAS—germ cell cancer	0.000169	0.00111	CbGpPWpGaD
Sulindac—Feeling abnormal—Methotrexate—germ cell cancer	0.000166	0.000865	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—FGF4—germ cell cancer	0.000166	0.00109	CbGpPWpGaD
Sulindac—MAPK3—CDC42 signaling events—HRAS—germ cell cancer	0.000166	0.00109	CbGpPWpGaD
Sulindac—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000165	0.000859	CcSEcCtD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	0.000162	0.00106	CbGpPWpGaD
Sulindac—Urticaria—Methotrexate—germ cell cancer	0.00016	0.000834	CcSEcCtD
Sulindac—Body temperature increased—Methotrexate—germ cell cancer	0.00016	0.00083	CcSEcCtD
Sulindac—MAPK3—Alzheimers Disease—TP53—germ cell cancer	0.000157	0.00103	CbGpPWpGaD
Sulindac—MAPK3—Leptin signaling pathway—HRAS—germ cell cancer	0.000157	0.00103	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CRABP1—germ cell cancer	0.000156	0.00102	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000156	0.00102	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000156	0.00102	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—TP53—germ cell cancer	0.000153	0.001	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—TP53—germ cell cancer	0.000153	0.001	CbGpPWpGaD
Sulindac—Hypersensitivity—Methotrexate—germ cell cancer	0.000149	0.000774	CcSEcCtD
Sulindac—MAPK3—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—germ cell cancer	0.000149	0.000978	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—H2AFZ—germ cell cancer	0.000148	0.000974	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—HRAS—germ cell cancer	0.000146	0.000959	CbGpPWpGaD
Sulindac—Asthenia—Methotrexate—germ cell cancer	0.000145	0.000753	CcSEcCtD
Sulindac—Pruritus—Methotrexate—germ cell cancer	0.000143	0.000743	CcSEcCtD
Sulindac—MAPK3—IRS-mediated signalling—HRAS—germ cell cancer	0.000142	0.000932	CbGpPWpGaD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—TP53—germ cell cancer	0.00014	0.000923	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—MYC—germ cell cancer	0.000139	0.000913	CbGpPWpGaD
Sulindac—Diarrhoea—Methotrexate—germ cell cancer	0.000138	0.000718	CcSEcCtD
Sulindac—MAPK3—IRS-related events—HRAS—germ cell cancer	0.000138	0.000906	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000138	0.000906	CbGpPWpGaD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—HRAS—germ cell cancer	0.000137	0.000898	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—KITLG—germ cell cancer	0.000136	0.000896	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—HRAS—germ cell cancer	0.000135	0.00089	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—FGFR3—germ cell cancer	0.000135	0.00089	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000134	0.00088	CbGpPWpGaD
Sulindac—Dizziness—Methotrexate—germ cell cancer	0.000134	0.000694	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—AVP—germ cell cancer	0.000133	0.000876	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—HRAS—germ cell cancer	0.000133	0.000875	CbGpPWpGaD
Sulindac—MAPK3—Insulin receptor signalling cascade—HRAS—germ cell cancer	0.000133	0.000875	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—HRAS—germ cell cancer	0.000133	0.000875	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—MYC—germ cell cancer	0.000133	0.000872	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	0.000132	0.00087	CbGpPWpGaD
Sulindac—Vomiting—Methotrexate—germ cell cancer	0.000128	0.000668	CcSEcCtD
Sulindac—PPARD—Gene Expression—H2AFZ—germ cell cancer	0.000128	0.000842	CbGpPWpGaD
Sulindac—Rash—Methotrexate—germ cell cancer	0.000127	0.000662	CcSEcCtD
Sulindac—Dermatitis—Methotrexate—germ cell cancer	0.000127	0.000661	CcSEcCtD
Sulindac—Headache—Methotrexate—germ cell cancer	0.000127	0.000658	CcSEcCtD
Sulindac—MAPK3—Innate Immune System—FGF4—germ cell cancer	0.000126	0.000831	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—KIT—germ cell cancer	0.000124	0.000817	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000122	0.000804	CbGpPWpGaD
Sulindac—Nausea—Methotrexate—germ cell cancer	0.00012	0.000624	CcSEcCtD
Sulindac—MAPK3—ErbB1 downstream signaling—HRAS—germ cell cancer	0.00012	0.000787	CbGpPWpGaD
Sulindac—MAPK3—Disease—SLC2A3—germ cell cancer	0.000118	0.000778	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—H2AFZ—germ cell cancer	0.000118	0.000778	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	0.000118	0.000775	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—HRAS—germ cell cancer	0.000117	0.000769	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PVRL2—germ cell cancer	0.000117	0.000766	CbGpPWpGaD
Sulindac—ALB—Hemostasis—CD9—germ cell cancer	0.000114	0.000751	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TP53—germ cell cancer	0.000114	0.00075	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—TP53—germ cell cancer	0.000113	0.000744	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—HRAS—germ cell cancer	0.000111	0.000732	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—HRAS—germ cell cancer	0.000111	0.000727	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—MYC—germ cell cancer	0.000108	0.000712	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000106	0.000699	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—MYC—germ cell cancer	0.000105	0.000688	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—HRAS—germ cell cancer	0.000104	0.000685	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—KITLG—germ cell cancer	0.000104	0.000683	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000102	0.000669	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGFR3—germ cell cancer	0.000101	0.000666	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.0001	0.000659	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	9.92e-05	0.000653	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—HRAS—germ cell cancer	9.45e-05	0.000622	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	9.44e-05	0.000621	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—OXT—germ cell cancer	9.44e-05	0.000621	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	9.43e-05	0.00062	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—KIT—germ cell cancer	9.3e-05	0.000611	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—HRAS—germ cell cancer	9.3e-05	0.000611	CbGpPWpGaD
Sulindac—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	9.24e-05	0.000608	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—MYC—germ cell cancer	9.19e-05	0.000604	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—HRAS—germ cell cancer	9.04e-05	0.000595	CbGpPWpGaD
Sulindac—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	9.03e-05	0.000594	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—HRAS—germ cell cancer	8.9e-05	0.000585	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—germ cell cancer	8.73e-05	0.000574	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	8.6e-05	0.000565	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—germ cell cancer	8.59e-05	0.000565	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—HRAS—germ cell cancer	8.54e-05	0.000562	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—HRAS—germ cell cancer	8.51e-05	0.000559	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—HRAS—germ cell cancer	8.5e-05	0.000559	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—HRAS—germ cell cancer	8.46e-05	0.000556	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—HRAS—germ cell cancer	8.42e-05	0.000554	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—HRAS—germ cell cancer	8.38e-05	0.000551	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—MYC—germ cell cancer	8.25e-05	0.000543	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—germ cell cancer	7.92e-05	0.000521	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—HRAS—germ cell cancer	7.88e-05	0.000518	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—HRAS—germ cell cancer	7.88e-05	0.000518	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	7.88e-05	0.000518	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—HRAS—germ cell cancer	7.81e-05	0.000514	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	7.79e-05	0.000513	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	7.75e-05	0.00051	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—HRAS—germ cell cancer	7.74e-05	0.000509	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGFR3—germ cell cancer	7.72e-05	0.000507	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—HRAS—germ cell cancer	7.71e-05	0.000507	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—SLC2A3—germ cell cancer	7.42e-05	0.000488	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGF4—germ cell cancer	7.36e-05	0.000484	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—SLC22A3—germ cell cancer	7.31e-05	0.000481	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—KIT—germ cell cancer	7.09e-05	0.000466	CbGpPWpGaD
Sulindac—PTGS2—Disease—SLC2A3—germ cell cancer	7.04e-05	0.000463	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	6.98e-05	0.000459	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—HRAS—germ cell cancer	6.8e-05	0.000447	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGF4—germ cell cancer	6.8e-05	0.000447	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—germ cell cancer	6.78e-05	0.000446	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	6.75e-05	0.000444	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—H2AFZ—germ cell cancer	6.54e-05	0.00043	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AVP—germ cell cancer	6.47e-05	0.000425	CbGpPWpGaD
Sulindac—MAPK3—Disease—H2AFZ—germ cell cancer	6.07e-05	0.000399	CbGpPWpGaD
Sulindac—MAPK3—Immune System—KITLG—germ cell cancer	6.05e-05	0.000398	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	6.01e-05	0.000395	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—germ cell cancer	5.98e-05	0.000394	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CRABP1—germ cell cancer	5.96e-05	0.000392	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SLC2A3—germ cell cancer	5.89e-05	0.000388	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—SLC22A3—germ cell cancer	5.81e-05	0.000382	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	5.61e-05	0.000369	CbGpPWpGaD
Sulindac—MAPK3—Disease—KITLG—germ cell cancer	5.58e-05	0.000367	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—OXT—germ cell cancer	5.58e-05	0.000367	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—HRAS—germ cell cancer	5.46e-05	0.000359	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—HRAS—germ cell cancer	5.37e-05	0.000353	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SLC2A3—germ cell cancer	5.23e-05	0.000344	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—SLC22A3—germ cell cancer	5.15e-05	0.000339	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MYC—germ cell cancer	5.12e-05	0.000336	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—HRAS—germ cell cancer	4.86e-05	0.00032	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC2A3—germ cell cancer	4.77e-05	0.000314	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGF4—germ cell cancer	4.76e-05	0.000313	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CRABP1—germ cell cancer	4.73e-05	0.000311	CbGpPWpGaD
Sulindac—ALB—Metabolism—SLC22A3—germ cell cancer	4.7e-05	0.000309	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	4.7e-05	0.000309	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.61e-05	0.000303	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—MYC—germ cell cancer	4.57e-05	0.000301	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGFR3—germ cell cancer	4.49e-05	0.000296	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—MYC—germ cell cancer	4.42e-05	0.000291	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—H2AFZ—germ cell cancer	4.25e-05	0.00028	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—germ cell cancer	4.2e-05	0.000276	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CRABP1—germ cell cancer	4.2e-05	0.000276	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGFR3—germ cell cancer	4.15e-05	0.000273	CbGpPWpGaD
Sulindac—MAPK3—Immune System—KIT—germ cell cancer	4.13e-05	0.000271	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—MYC—germ cell cancer	4.09e-05	0.000269	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGF4—germ cell cancer	4.04e-05	0.000266	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—HRAS—germ cell cancer	4.02e-05	0.000264	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—KITLG—germ cell cancer	3.91e-05	0.000257	CbGpPWpGaD
Sulindac—ALB—Metabolism—CRABP1—germ cell cancer	3.83e-05	0.000252	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AVP—germ cell cancer	3.82e-05	0.000251	CbGpPWpGaD
Sulindac—MAPK3—Disease—KIT—germ cell cancer	3.81e-05	0.000251	CbGpPWpGaD
Sulindac—PTGS2—Disease—H2AFZ—germ cell cancer	3.61e-05	0.000237	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—germ cell cancer	3.56e-05	0.000234	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—HRAS—germ cell cancer	3.47e-05	0.000228	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—HRAS—germ cell cancer	3.4e-05	0.000224	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—germ cell cancer	3.36e-05	0.000221	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC2A3—germ cell cancer	3.34e-05	0.000219	CbGpPWpGaD
Sulindac—PTGS2—Disease—KITLG—germ cell cancer	3.32e-05	0.000218	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—SLC22A3—germ cell cancer	3.29e-05	0.000216	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—HRAS—germ cell cancer	3.06e-05	0.000201	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGFR3—germ cell cancer	2.91e-05	0.000191	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CRABP1—germ cell cancer	2.68e-05	0.000176	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—KIT—germ cell cancer	2.67e-05	0.000175	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGFR3—germ cell cancer	2.47e-05	0.000162	CbGpPWpGaD
Sulindac—PTGS2—Disease—KIT—germ cell cancer	2.27e-05	0.000149	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—MYC—germ cell cancer	2.26e-05	0.000148	CbGpPWpGaD
Sulindac—MAPK3—Disease—MYC—germ cell cancer	2.1e-05	0.000138	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—HRAS—germ cell cancer	1.95e-05	0.000128	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HRAS—germ cell cancer	1.78e-05	0.000117	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—germ cell cancer	1.71e-05	0.000113	CbGpPWpGaD
Sulindac—MAPK3—Disease—HRAS—germ cell cancer	1.65e-05	0.000108	CbGpPWpGaD
Sulindac—ALB—Hemostasis—HRAS—germ cell cancer	1.64e-05	0.000108	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MYC—germ cell cancer	1.47e-05	9.65e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MYC—germ cell cancer	1.25e-05	8.2e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—germ cell cancer	1.21e-05	7.93e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HRAS—germ cell cancer	1.15e-05	7.58e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—HRAS—germ cell cancer	9.79e-06	6.44e-05	CbGpPWpGaD
